Cellply
C
Active
· 2013· 25 peopleDeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.
About
Cellply is a Bologna-based DeepTech startup focused on developing advanced analytical tools for the deep characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics. Their flagship product, VivaCyte®, is an automated analytical system that utilizes patented microfluidic technology, AI-powered image analysis, and dedicated software to enable rapid discovery and process development of cell therapies at single-cell resolution. The company aims to accelerate the adoption of Advanced Therapy Medicinal Products (ATMPs) by providing innovative quality control solutions that enhance potency and persistence, and streamline batch release and potency assays.
Tags
Total Employees
25
Current headcount
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Cellply do?
Cellply is a Bologna-based DeepTech startup focused on developing advanced analytical tools for the deep characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics. Their flagship product, VivaCyte®, is an automated analytical system that utilizes patented microfluidic technology, AI-powered image analysis, and dedicated software to enable rapid discovery and process development of cell therapies at single-cell resolution. The company aims to accelerate the adopti…
How much funding has Cellply raised?
Cellply has raised a total of $7M in funding. The most recent round on record is Funding Round.
Where is Cellply headquartered?
Cellply is headquartered in Bologna, Italy.
When was Cellply founded?
Cellply was founded in 2013.
What industry does Cellply operate in?
Cellply operates in Biotechnology, HealthTech, Artificial Intelligence, Medical Devices.
How many employees does Cellply have?
Cellply has approximately 25 people on record.